Wordt geladen...
Disparities in Access to Sorafenib in Communities with Low Socioeconomic Status
OBJECTIVE. In the United States, hepatocellular carcinoma (HCC) is more common among communities with low socioeconomic status (SES), and these groups tend to be diagnosed with later-stage cancers. Sorafenib is the primary treatment for advanced HCC, however its substantial cost raises concern for a...
Bewaard in:
| Gepubliceerd in: | J Health Care Poor Underserved |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7510390/ https://ncbi.nlm.nih.gov/pubmed/30122687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1353/hpu.2018.0083 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|